Bavarian Nordic Secures $157M Contract to Replenish US Supplies of Smallpox/Mpox Vaccine Jynneos

Bavarian Nordic Secures $157M Contract to Replenish US Supplies of Smallpox/Mpox Vaccine Jynneos Bavarian Nordic, a Danish biotechnology company, has recently secured a substantial contract worth $156.8 million from the United States government to replenish the nation’s stockpile of the smallpox and mpox vaccine, Jynneos. This deal marks a significant milestone for Bavarian Nordic as […]

WHO Prequalifies Biological E’s Novel Oral Polio Vaccine Type 2

WHO Prequalifies Biological E’s Novel Oral Polio Vaccine Type 2 In a landmark achievement for global health, the World Health Organization (WHO) has granted pre-qualification status to Biological E’s novel oral polio vaccine type 2 (NOPV2). This development marks a significant milestone in the ongoing battle against polio, particularly in regions afflicted by circulating vaccine-derived […]